Clinical response of CARD14-associated papulosquamous eruption to an anti-interleukin-17A antibody

Br J Dermatol. 2022 Sep;187(3):419-422. doi: 10.1111/bjd.21229. Epub 2022 May 20.

Abstract

Here we present another family with CARD14-associated papulosquamous eruption, which is characterized by mutations in CARD14 and skin lesions resembling psoriasis and pityriasis rubra pilaris. We show beneficial therapeutic response to anti-IL17A treatment in one patient and performed immunomonitoring of our patient, exhibiting enhanced pSTAT3 levels in T cells before treatment, which normalized after treatment. Together, our data support the pathogenic role of IL-17A in this disease, which might have consequences for future treatment decisions in this rare condition.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • CARD Signaling Adaptor Proteins / genetics
  • Exanthema*
  • Guanylate Cyclase / genetics
  • Humans
  • Interleukin-17 / genetics
  • Membrane Proteins / genetics
  • Mutation / genetics
  • Pityriasis Rubra Pilaris* / drug therapy
  • Pityriasis Rubra Pilaris* / genetics
  • Psoriasis* / genetics

Substances

  • CARD Signaling Adaptor Proteins
  • Interleukin-17
  • Membrane Proteins
  • CARD14 protein, human
  • Guanylate Cyclase